Materialise NV Capital Stock Change

Capital Stock Change of MTLS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capital Stock Change growth rates and interactive chart.


Highlights and Quick Summary

  • Capital Stock Change for the quarter ending September 29, 2021 was $11.6 Million (a -87.07% decrease compared to previous quarter)
  • Year-over-year quarterly Capital Stock Change increased by 123096.81%
  • Annual Capital Stock Change for 2020 was $4.7 Million (a 230.74% increase from previous year)
  • Annual Capital Stock Change for 2019 was $1.42 Million (a -98.01% decrease from previous year)
  • Annual Capital Stock Change for 2018 was $71.4 Million (a 10999.67% increase from previous year)
  • Twelve month Capital Stock Change ending September 29, 2021 was $106 Million (a 12.12% increase compared to previous quarter)
  • Twelve month trailing Capital Stock Change increased by 3275.58% year-over-year
Trailing Capital Stock Change for the last four month:
29 Sep '21 29 Jun '21 30 Dec '20 29 Sep '20
$106 Million $94.3 Million $6.12 Million $3.13 Million
Visit stockrow.com/MTLS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capital Stock Change of Materialise NV

Most recent Capital Stock Changeof MTLS including historical data for past 10 years.

Interactive Chart of Capital Stock Change of Materialise NV

Materialise NV Capital Stock Change for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $11.58 $89.58
2020 $4.53 $0.01 $0.15 $4.7
2019 $1.42 $1.42
2018 $1.55 $69.64 $-0.01 $0.25 $71.44
2015 $0.64

Business Profile of Materialise NV

Sector: Technology
Industry: Software—Application
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. It operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.